HomeComparePHYOF vs GBDC

PHYOF vs GBDC: Dividend Comparison 2026

PHYOF yields 2857.14% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PHYOF wins by $285724556539.31M in total portfolio value
10 years
PHYOF
PHYOF
● Live price
2857.14%
Share price
$0.07
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$285724556560.08M
Annual income
$267,319,527,558,731,650.00
Full PHYOF calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — PHYOF vs GBDC

📍 PHYOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPHYOFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PHYOF + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PHYOF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PHYOF
Annual income on $10K today (after 15% tax)
$242,857.14/yr
After 10yr DRIP, annual income (after tax)
$227,221,598,424,921,900.00/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, PHYOF beats the other by $227,221,598,410,991,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PHYOF + GBDC for your $10,000?

PHYOF: 50%GBDC: 50%
100% GBDC50/50100% PHYOF
Portfolio after 10yr
$142862278290.43M
Annual income
$133,659,763,787,560,450.00/yr
Blended yield
93.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

PHYOF
No analyst data
Altman Z
0.5
Piotroski
2/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PHYOF buys
0
GBDC buys
0
No recent congressional trades found for PHYOF or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPHYOFGBDC
Forward yield2857.14%11.85%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$285724556560.08M$20.78M
Annual income after 10y$267,319,527,558,731,650.00$16,389,263.41
Total dividends collected$284448663636.43M$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: PHYOF vs GBDC ($10,000, DRIP)

YearPHYOF PortfolioPHYOF Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$296,414$285,714.29$12,490$1,790.28+$283.9KPHYOF
2$8,232,097$7,914,934.20$16,522$3,157.73+$8.22MPHYOF
3$214,243,566$205,435,221.63$23,578$5,898.68+$214.22MPHYOF
4$5,225,999,702$4,996,759,086.15$37,115$11,886.75+$5225.96MPHYOF
5$119,502,966,841$113,911,147,159.88$66,136$26,423.57+$119502.90MPHYOF
6$2,562,267,139,226$2,434,398,964,706.24$137,257$66,491.44+$2562267.00MPHYOF
7$51,522,962,512,220$48,781,336,673,248.19$341,734$194,868.54+$51522962.17MPHYOF
8$971,869,901,477,056$916,740,331,588,980.50$1,050,788$685,133.02+$971869900.43MPHYOF
9$17,200,961,683,505,388$16,161,060,888,924,940.00$4,099,314$2,974,971.01+$17200961679.41MPHYOF
10$285,724,556,560,082,430$267,319,527,558,731,650.00$20,775,530$16,389,263.41+$285724556539.31MPHYOF

PHYOF vs GBDC: Complete Analysis 2026

PHYOFStock

IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, Netherlands, Ireland, rest of Europe, the United States, and internationally. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company's technologies comprise Assessa, a secure online digital platform that provides clinical decision support for patient selection and post-marketing surveillance; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer. Its focused therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis and other demyelinating diseases, Progressive Supranuclear Palsy, and other rare neurological diseases. The company also engages in the data collection, optimization, and analytics of rare neurological disorders; offers drug development analytics, imaging operation services, and post marketing surveillance services, as well as consultancy services; and provides end-to-end services, such as trail design and consultation, project management, imaging site set-up and management, data management, reading and analysis, and regulatory pathway. IXICO plc was incorporated in 1995 and is based in London, the United Kingdom.

Full PHYOF Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this PHYOF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PHYOF vs SCHDPHYOF vs JEPIPHYOF vs OPHYOF vs KOPHYOF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.